MiR21 sensitized B-lymphoma cells to ABT-199 via ICOS/ICOSL-mediated interaction of Treg cells with endothelial cells - Test2 - elhamkhani - TriplyDB

MiR21 sensitized B-lymphoma cells to ABT-199 via ICOS/ICOSL-mediated interaction of Treg cells with endothelial cells

MiR21 sensitized B-lymphoma cells to ABT-199 via ICOS/ICOSL-mediated interaction of Treg cells with endothelial cells

http://www.wikidata.org/entity/Q33823801

about

Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.Circulating miRNAs as biomarkers in diffuse large B-cell lymphoma: a systematic review.

P2860

Q54918383-348A1CE9-1F16-427A-BF68-23382D27D826 Q55119635-8A54AF3F-ED28-46FE-8CC9-C09123C24BC7

P2860

MiR21 sensitized B-lymphoma cells to ABT-199 via ICOS/ICOSL-mediated interaction of Treg cells with endothelial cells

http://www.wikidata.org/entity/Q33823801

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

MiR21 sensitized B-lymphoma ce ...... g cells with endothelial cells

@ast

MiR21 sensitized B-lymphoma ce ...... g cells with endothelial cells

@en

type

label

MiR21 sensitized B-lymphoma ce ...... g cells with endothelial cells

@ast

MiR21 sensitized B-lymphoma ce ...... g cells with endothelial cells

@en

prefLabel

MiR21 sensitized B-lymphoma ce ...... g cells with endothelial cells

@ast

MiR21 sensitized B-lymphoma ce ...... g cells with endothelial cells

@en

P1433

Q33823801-E4F22B94-6DED-481C-A319-892F93823196

P1476

Q33823801-7C2075E2-A38D-4A16-A578-814629DA2605

P2093

Q33823801-03418E62-6A1D-4257-A87C-A40338DF2904

Q33823801-054BDD35-E0F2-4823-BFE7-3C0820AA71F2

Q33823801-1C6FDBBC-6C71-4018-8CBD-55151424D75F

Q33823801-30027846-4930-49DE-823E-D024C490AAC7

Q33823801-3A8CDABD-1C2F-44F5-9B0A-D3A209AA97C0

Q33823801-7962C6B4-BA50-4E1F-99BA-490A4F40F6FA

Q33823801-7EC9FCB0-B201-4C74-AD5E-7527447E746A

Q33823801-84D6ECAF-A1CC-43B7-84F4-76F7F8D8D308

Q33823801-9682C298-1793-4B9E-B093-E3C1B1A63E32

Q33823801-A19BC4D4-9F24-4613-B194-C091D30529BC

P2860

Q33823801-11A57249-FB68-40DD-ACA9-82C323008B47

Q33823801-237FDE09-377B-4448-8A1F-E4B168134D66

Q33823801-2E5219E8-F876-4F04-A9B8-5A872CC34364

Q33823801-2EA45431-96E3-427B-BF00-8CDD9A5853F3

Q33823801-32084B5C-AF83-4C35-A911-178A353A0FE4

Q33823801-3235A81E-CD06-4BCB-B76E-06DBE53F96AA

Q33823801-3A17A9F9-98CA-4C6C-BBCB-7D568D91BB80

Q33823801-462D174F-8BD0-43C8-BFBD-1174F49D47FA

Q33823801-4755B135-EA5C-4B59-A889-0FEEF92794A5

Q33823801-4937E515-8188-483E-B73F-39F7372CAAF2

P2888

Q33823801-84CF691D-3FA2-46D6-90C3-C3B521C9C919

P304

Q33823801-65F715A0-7E8B-44B7-9E11-CF57E5F94C6E

P31

Q33823801-7396114C-1B31-4675-ADFF-E283ECDFF08F

P356

Q33823801-C6936798-32A9-4258-9CEE-6974C5AE2F4E

P433

Q33823801-F414064D-D550-4279-8B99-D849C9E17129

P478

Q33823801-85F0D8F7-4752-48FE-BF76-C414A8C25AD6

P577

Q33823801-3404EDC2-1642-4FFE-96A1-B1448C3B6BD7

P6179

Q33823801-76452CAE-3348-4F31-949D-D1649D623E51

P698

Q33823801-509CC533-84A3-45E4-B742-E8BD9E5CC3B3

P921

Q33823801-53319A42-2F61-4A34-ABD8-F78C1565A76F

P932

Q33823801-BB4ECFB1-916F-4CE0-B002-DDB95693D5BD

P356

S13046-017-0551-Z

P1433

Journal of Experimental & Clinical Cancer Research

P1476

MiR21 sensitized B-lymphoma ce ...... g cells with endothelial cells

@en

P2093

Anne Janin

http://www.w3.org/2001/XMLSchema#string

Bin Qu

http://www.w3.org/2001/XMLSchema#string

Hui-Jin Zhao

http://www.w3.org/2001/XMLSchema#string

Hui-Juan Zhong

http://www.w3.org/2001/XMLSchema#string

Jie Xiong

http://www.w3.org/2001/XMLSchema#string

Li Wang

http://www.w3.org/2001/XMLSchema#string

Peng-Peng Xu

http://www.w3.org/2001/XMLSchema#string

Wei-Li Zhao

http://www.w3.org/2001/XMLSchema#string

Xiang-Qin Weng

http://www.w3.org/2001/XMLSchema#string

Xue-Feng Wang

http://www.w3.org/2001/XMLSchema#string

P2860

BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents

MicroRNA-target interactions: new insights from genome-wide approaches

ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

The tumor microenvironment shapes hallmarks of mature B-cell malignancies.

Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

ABT-199, a new Bcl-2-specific BH3 mimetic, has in vivo efficacy against aggressive Myc-driven mouse lymphomas without provoking thrombocytopenia.

Myc-induced microRNAs integrate Myc-mediated cell proliferation and cell fate.

OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma.

The B7-CD28 superfamily.

P2888

s13046-017-0551-z

P304

82

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13046-017-0551-Z

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1086110826

http://www.w3.org/2001/XMLSchema#string

P698

28637496

http://www.w3.org/2001/XMLSchema#string

P921

P932

5480196

http://www.w3.org/2001/XMLSchema#string